MOMasahiro Okada

Masahiro Okada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Masahiro Okada has a total of 139 co-authors. Here are the top co-authors by number of shared publications:

  • Naohito Hato

    Department of Otolaryngology‐Head and Neck Surgery Ehime University Graduate School of Medicine Toon Japan

    18 shared publications
  • Masato Teraoka

    Department of Emergency and Critical Care Medicine, Ehime University Graduate School of Medicine, Toon, Japan

    11 shared publications
  • Taro Takagi

    Department of Emergency and Critical Care Medicine, Ehime University Graduate School of Medicine, Toon, Japan

    8 shared publications
  • Hiroyuki Yamada

    Department of Otolaryngology, Head and Neck Surgery, Ehime University Graduate School of Medicine, Toon, Japan

    7 shared publications
  • Kiyofumi Gyo

    Department of Otolaryngology, Head and Neck Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan; Department of Otolaryngology, Takanoko Hospital, 525-1 Takanoko, Matsuyama, Ehime, Japan

    6 shared publications
  • Daiki Takagi

    Department of Otorhinolaryngology, HITO Hospital, Ehime, Japan

    5 shared publications

Latest Publications

  • Open Access

    Efficacy of Concentrated Growth Factors in Treating Tympanic Membrane Perforation in Guinea Pigs

    by Takahiro Hanari, Masahiro Okada, Takahiro Nakata, Sawa Asoh, Eriko Nishihara, Masato Teraoka, Naohito Hato

    Background: Less invasive and cost-effective alternatives are needed to manage tympanic membrane perforation (TMP). Therefore, the effectiveness of concentrated growth factors (CGF) in promoting tympanic membrane regeneration in guinea pig models of eardrum perforation was invetigeted. Methods: Large TMPs were created in 34 guinea pig ears using a CO2 laser and divided into 3 groups: CGF-gelatin sponge (with-CGF group), saline-gelatin sponge (without-CGF group), and untreated group. In the with-CGF group, CGF and gelatin sponges were implanted into the perforations, while the without-CGF group received gelatin sponges impregnated with saline. Eardrums were observed under a light microscope on days 14 and 28, and tympanic membranes were examined histologically with hematoxylin and eosin staining. Results: On day 14, 8 of 14 (57.1%) ears in the with-CGF group achieved perforation closure, while no closures were observed in the withoutCGF or untreated groups. The closure rate was significantly higher in the with-CGF group compared to both without-CGF and untreated groups (P < .001). By day 28, 12 of 14 (85.7%) ears in the with-CGF group and 8 of 14 (57.1%) ears in the without-CGF group had closure. No closures were noted in the untreatedgroup. Although the closure rates between the with-CGF and without-CGF groups were similar (P=.07), the withCGF group showed a significantly higher rate than the untreated group (P < .001). Histological analysis revealed that the regenerated tympanic membrane was thicker in the with-CGF group compared to the without-CGF group. Conclusion: Concentrated growth factor effectively promotes tympanic membrane regeneration and provides a promising, minimally invasive treatment option for TMP.


  • Oral Intake Difficulty and Aspiration Pneumonia Assessment Using High‐Resolution Manometry

    by Kaori Nishikubo‐Tanaka, Rie Asayama, Kazutaka Kochi, Masahiro Okada, Keiko Tanaka, Hiroyuki Yamada, Naohito Hato

    Objective: The sequential generation of swallowing pressure (SP) from the nasopharynx to the proximal esophagus is important for the bolus to pass from the oral cavity to the esophagus. The purpose of this study was to investigate the correlation of the SP sequence mode on high‐resolution manometry (HRM) with oral intake difficulty and aspiration pneumonia.Methods: Consecutive patients with dysphagia who were admitted to our dysphagia clinic between November 2016 and November 2020 were enrolled in this cross‐sectional study. We classified the HRM pressure topography data according to the SP sequence mode into type A, normal; B, partially decreased; C, totally decreased; and D, sequence disappeared, and according to the upper esophageal sphincter (UES) during pharyngeal swallowing into type 1, flattening and 2, non‐flattening. Clinical dysphagia severity was determined based on oral intake difficulty and aspiration pneumonia.Results: In total, 202 patients with dysphagia (mean [standard deviation] age, 68.3 [14.5] years; 140 [69.8%] male) were enrolled. Type C (odds ratio [OR], 10.48; 95% confidence interval [CI], 2.89–51.45), type D (OR, 19.90; 95% CI, 4.18–122.35), and type 2 (OR, 6.36; 95% CI, 2.88–14.57) were significantly related to oral intake difficulty. Type C (OR, 3.23; 95% CI, 1.08–11.12) and type 2 (OR, 4.18; 95% CI, 1.95–9.15) were significantly associated with aspiration pneumonia.Conclusion: The failure of sequential generation of SP was associated with higher risk of oral intake difficulty and aspiration pneumonia. These assessments are useful in understanding the pathophysiology and severity of dysphagia and in selecting safety nutritional management methods.Level of Evidence: 4 Laryngoscope, 134:2127–2135, 2024


  • Open Access

    Cricotracheostomy for patients with severe COVID-19: A case control study

    by Naoki Mukai, Masahiro Okada, Saki Konishi, Mitsuo Okita, Siro Ogawa, Kosuke Nishikawa, Suguru Annen, Muneaki Ohshita, Hironori Matsumoto, Satoru Murata, et al.

    Background: Tracheostomy is an important procedure for the treatment of severe coronavirus disease-2019 (COVID-19). Older age and obesity have been reported to be associated with the risk of severe COVID-19 and prolonged intubation, and anticoagulants are often administered in patients with severe COVID-19; these factors are also related to a higher risk of tracheostomy. Cricotracheostomy, a modified procedure for opening the airway through intentional partial cricoid cartilage resection, was recently reported to be useful in cases with low-lying larynx, obesity, stiff neck, and bleeding tendency. Here, we investigated the usefulness and safety of cricotracheostomy for severe COVID-19 patients.Materials and methods: Fifteen patients with severe COVID-19 who underwent cricotracheostomy between January 2021 and April 2022 with a follow-up period of ≥ 14 days were included in this study. Forty patients with respiratory failure not related to COVID-19 who underwent traditional tracheostomy between January 2015 and April 2022 comprised the control group. Data were collected from medical records and comprised age, sex, body mass index, interval from intubation to tracheostomy, use of anticoagulants, complications of tracheostomy, and decannulation.Results: Age, sex, and days from intubation to tracheostomy were not significantly different between the COVID-19/cricotracheostomy and control/traditional tracheostomy groups. Body mass index was significantly higher in the COVID-19 group than that in the control group (P = 0.02). The rate of use of anticoagulants was significantly higher in the COVID-19 group compared with the control group (P < 0.01). Peri-operative bleeding, subcutaneous emphysema, and stomal infection rates were not different between the groups, while stomal granulation was significantly less in the COVID-19 group (P = 0.04).Conclusions: These results suggest that cricotracheostomy is a safe procedure in patients with severe COVID-19.


  • Open Access

    A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss

    by Masahiro Okada, Hideo Ogawa, Taro Takagi, Eriko Nishihara, Tadashi Yoshida, Jun Hyodo, Yusuke Shinomori, Nobumitsu Honda, Takashi Fujiwara, Masato Teraoka, et al.

    Background: Hydrogen (H2) has been reported to be effective in reducing hearing loss due to several causes in animal studies. However, no study has examined the effectiveness of H2 in treating hearing loss in humans. Thus, we investigated whether H2 is effective for the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL).Materials and methods: We conducted a double-blind randomized controlled trial at six hospitals between June 2019 and March 2022. The study protocol and trial registration have been published in the Japan Registry of Clinical Trials (jRCT, No. jRCTs06119004). We randomly assigned patients with ISSNHL to receive either H2 (H2 group) or air as a placebo (control group) through inhalation combined with the administration of systemic glucocorticoids and prostaglandin E1. The primary outcome was the hearing threshold and changes in hearing threshold 3 months after therapy. In contrast, the secondary outcomes included the proportion of patients with a good prognosis (complete recovery or marked improvement).Results: Sixty-five patients with ISSNHL (31 and 34 in the H2 and control groups, respectively) were included in this study. The hearing threshold 3 months after treatment was not significantly different between the groups; 39.0 decibels (dB) (95% confidence interval [CI]: 28.7–49.3) and 49.5 dB (95% CI: 40.3–58.7) in the H2 and control groups, respectively. In contrast, the changes in hearing threshold 3 months after treatment was 32.7 dB (95% CI: 24.2–41.3) and 24.2 dB (95% CI: 18.1–30.3) in the H2 and control groups, respectively. Consequently, the changes in hearing threshold were significantly better in the H2 group than in the control group (P = 0.048). However, no adverse effects due to the inhalation of H2 gas have been reported.Conclusion: This is the first study to investigate the efficacy of H2 for the treatment of ISSNHL in humans. The results suggest that H2 therapy may be effective for ISSNHL treatment.Clinical trial registration: [https://jrct.niph.go.jp/re/reports/detail/10442], identifier [jRCTs06119004].


  • Open Access

    Laryngeal complications after endotracheal intubation and prone positioning in patients with coronavirus disease 2019

    by Shiori Aibara, Masahiro Okada, Kaori Tanaka‐Nishikubo, Rie Asayama, Eriko Sato, Hirofumi Sei, Kunihide Aoishi, Taro Takagi, Masato Teraoka, Naoki Mukai, et al.

    Objectives: Laryngeal complications have been reported after endotracheal intubation and prone positioning in patients with critical coronavirus disease 2019 (COVID‐19), but their association is unclear. In this study, we investigated the rate of laryngeal complications in patients with COVID‐19 compared to an alternative condition (control group).Methods: We retrospectively analyzed the data of 40 patients who underwent endotracheal intubation for either COVID‐19 or an alternative condition (control group). Data on age, sex, body mass index (BMI), cardiovascular disease (CVD) risk factors, use of prone therapy, duration of endotracheal intubation, and duration from extubation/tracheostomy to laryngeal evaluation were collected from medical records.Results: There were no significant differences in BMI, frequency of CVD risk factors, duration of endotracheal intubation, or duration from extubation/tracheostomy to laryngeal evaluation between the two groups. In the COVID‐19 group, all patients adopted the prone position. In comparison, only one patient in the control group adopted the prone position. Significant differences were observed between the two groups regarding the incidence of vocal fold immobility and laryngeal granuloma.Conclusion: Laryngeal complications were more common in the COVID‐19 group than in the control group. Prone positioning may be a risk factor for these complications.Level of Evidence: 4.


  • Open Access

    Complete resection of residual rectal dysplasia in a patient with ulcerative colitis using the pocket-creation method

    by Toshihiro Fujinuma, Takahito Takezawa, Masahiro Okada, Yoshikazu Hayashi, Yusuke Amano, Alan Kawarai Lefor, Hironori Yamamoto

    Formerly, when ulcerative colitis-associated neoplasia (UCAN) was identified, total colectomy was required to prevent future colorectal cancers. Since the introduction of the SCENIC guideline (2015) [1], endoscopic resection of UCAN is gradually being accepted. UCANs are however obscurely demarcated and have severe submucosal fibrosis, which makes endoscopic R0 resection challenging. Although multiple biopsies can be helpful to demarcate UCAN, they make the resection more challenging. The pocket-creation method (PCM) of endoscopic submucosal dissection (ESD) is good for resecting fibrotic submucosa, such as that under nongranular laterally spreading tumors [2] or after endoscopic interventions including biopsies. We illustrate the complete endoscopic resection of an area of rectal dysplasia in a patient with UC using the PCM. The patient was a 67-year-old man who had an 18-year history of UC. Although he had undergone endoscopic mucosal resection (EMR) of an adenoma in the distal rectum 3 years previously, the resection margin was pathologically positive, and a surveillance colonoscopy 2 years after the resection revealed residual dysplasia. He was referred to our hospital because he wanted to undergo endoscopic local resection instead of total colectomy. After he had received 3 months of concurrent treatment with 5-aminosalicylic acid enemas for the still inflamed rectum, along with oral 5-aminosalicylic acid and vedolizumab, a slightly red elevated lesion was identified ([Fig. 1]). Multiple biopsies were taken from this elevated area and also from the surrounding mucosa to determine the extent of the dysplasia, with the outermost biopsies being found to be negative for dysplasia. The PCM was performed after the area of dysplasia had been demarcated by reference to the surrounding negative biopsies ([Video 1]). Despite severe submucosal fibrosis caused by chronic inflammation, the previous EMR, and the multiple biopsies ([Fig. 2]), en bloc resection was achieved, without any adverse events. Pathologic evaluation revealed a low grade dysplastic lesion, with a negative margin ([Fig. 3]). Video 1 Complete resection of residual rectal dysplasia after endoscopic mucosal resection in a patient with ulcerative colitis using the pocket-creation method of endoscopic submucosal dissection. This patient demonstrates that rectal dysplasia with severe submucosal fibrosis due to UC and previous multiple endoscopic interventions can be safely and completely resected using the PCM. Endoscopy_UCTN_Code_CCL_1AD_2AD Article published online: 01 September 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Imaging characteristics of hypertrophic pachymeningitis due to ANCA-associated vasculitis

    by Taro Takagi, Masahiro Okada, Masashi Nakamura, Takahiro Hanari, Takahiro Nakata, Masato Teraoka, Naohito Hato


  • Association of the prognosis and severity of idiopathic sudden sensorineural hearing loss with cervical ultrasonographic findings

    by Takahiro Nakata, Masahiro Okada, Takahiro Hanari, Taro Takagi, Takashi Fujiwara, Naohito Hato


  • The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis

    by Yuki Hosokawa, Masahiro Okada, Koichiro Suemori, Naohiko Hamaguchi, Ken-Ichi Miyoshi, Taro Takagi, Masato Teraoka, Hiroyuki Yamada, Jun Ishizaki, Takuya Matsumoto, et al.


  • The hearing prognosis of otitis media with ANCA-associated vasculitis

    by Shinji Iwata, Masahiro Okada, Koichiro Suemori, Masato Teraoka, Hiroyuki Yamada, Jun Ishizaki, Takuya Matsumoto, Naohito Hato